Targeting PD-1/PD-L1 in lung cancer: current perspectives

Targeting PD-1/PD-L1 in lung cancer: current perspectives

María González-Cao,1 Niki Karachaliou,1 Santiago Viteri,1 Daniela Morales-Espinosa,1 Cristina Teixidó,2 Jesús Sánchez Ruiz,3 Miquel Ángel Molina-Vila,2 Mariacarmela Santarpia,4 Rafael Rosell1,2,5,61Translational Cancer Research Unit,...

Full description

Bibliographic Details
Main Authors:	González-Cao M, Karachaliou N, Viteri S, Morales-Espinosa D, Teixidó C, Sánchez Ruiz J, Molina-Vila MÁ, Santarpia M, Rosell R
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-07-01
Series:	Lung Cancer : Targets and Therapy
Online Access:	http://www.dovepress.com/targeting-pd-1pd-l1-in-lung-cancer-current-perspectives-peer-reviewed-article-LCTT

Similar Items

Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
by: Mariacarmela Santarpia, et al.
Published: (2020-06-01)

Tumor immune microenvironment characterization and response to anti-PD-1 therapy
by: Mariacarmela Santarpia, et al.
Published: (2015-06-01)

Assays for predicting and monitoring responses to lung cancer immunotherapy
by: Cristina Teixidó, et al.
Published: (2015-06-01)

Erratum to Assays for predicting and monitoring responses to lung cancer immunotherapy
by: Cristina Teixidó, et al.
Published: (2015-09-01)

Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints
by: Niki Karachaliou, et al.
Published: (2015-06-01)

Advances in immunotherapy for treatment of lung cancer
by: Jean G. Bustamante Alvarez, et al.
Published: (2015-09-01)

Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis
by: Mart&iacute;nez-Santana V, et al.
Published: (2013-07-01)

Patients' empowerment , physicians' perceptions, and achievement of therapeutic goals in patients with type 1 and type 2 diabetes mellitus in Mexico
by: Lavalle-González FJ, et al.
Published: (2016-07-01)

Functionalization of immunostimulating complexes (ISCOMs) with lipid vinyl sulfones and their application in immunological techniques and therapy
by: Cruz-Bustos T, et al.
Published: (2012-12-01)

Congenital malformations in Ecuadorian children: urgent need to create a National Registry of Birth Defects
by: Fabricio Gonz&aacute;lez-Andrade, et al.
Published: (2010-04-01)

Role of the transient receptor potential vanilloid 1 in inflammation and sepsis
by: Devesa I, et al.
Published: (2011-05-01)

Progress on PD-1/PD-L1 Checkpoint Inhibitors in Lung Cancer
by: Di ZHANG, et al.
Published: (2019-06-01)

Targeting the PD-1/PD-L1 axis in the treatment of lung cancer
by: Matikas Alexios, et al.
Published: (2016-03-01)

New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1
by: Nicolas Villanueva, et al.
Published: (2018-09-01)

Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure
by: Ranjan Pathak, et al.
Published: (2020-12-01)

Progress of PD-1/PD-L1 Inhibitors in Non-small Cell Lung Cancer
by: Zhansheng JIANG, et al.
Published: (2017-02-01)

PD-1/PD-L1 blockades in non-small-cell lung cancer therapy
by: Jing W, et al.
Published: (2016-01-01)

Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China
by: Si-Yang Liu, et al.
Published: (2017-07-01)

Congenital anophthalmia and microphthalmia: epidemiology and orbitofacial rehabilitation
by: Llorente-Gonz&aacute;lez S, et al.
Published: (2011-12-01)

Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors
by: Sarah J. Dart, et al.
Published: (2021-07-01)

Cognitive plasticity in normal and pathological aging
by: Fernández-Ballesteros R, et al.
Published: (2012-01-01)

Targeting the PD-1/PD-L1 Axis in Human Vitiligo
by: Marcella Willemsen, et al.
Published: (2020-11-01)

Study on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis
by: M&aacute;rquez-Balb&aacute;s G, et al.
Published: (2011-06-01)

PD-1/PD-L1 immunotherapy blockade in solid tumors: role of PD-1/PD-L1 in cancer disease progression
by: Li, Vivian
Published: (2021)

Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells.
by: Fei Yan, et al.
Published: (2016-01-01)

Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non–Small Cell Lung Cancer
by: Jia-Xin Li MB, et al.
Published: (2019-12-01)

The Lebanese–Syrian crisis: impact of influx of Syrian refugees to an already weak state
by: Cherri Z, et al.
Published: (2016-07-01)

Support for the initial attachment, growth and differentiation of MG-63 cells: a comparison between nano-size hydroxyapatite and micro-size hydroxyapatite in composites
by: Filová E, et al.
Published: (2014-08-01)

The intrinsic PD-L1 promotes cellular invasiveness via their PD-1 receptor in lung adenocarcinoma cells
by: Shuen-RuYang, et al.
Published: (2017)

Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer
by: Chaoyue Su, et al.
Published: (2020-09-01)

Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm
by: Giuseppe Luigi Banna, et al.
Published: (2020-07-01)

Clinical Research Progress of Anti PD-1/PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer
by: Zhiyu HUANG, et al.
Published: (2015-11-01)

Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer
by: Nitin Roper, et al.
Published: (2021-06-01)

Evolution of visual performance in 70 eyes implanted with the Tecnis&reg; ZMB00 multifocal intraocular lens
by: Palomino Bautista C, et al.
Published: (2012-03-01)

The PD-1:PD-L1 axis in Inflammatory Arthritis
by: Mary Canavan, et al.
Published: (2021-01-01)

PD-L1/PD-1 Axis in Glioblastoma Multiforme
by: Jakub Litak, et al.
Published: (2019-10-01)

PD-1/PD-L1 Inhibitors in Cervical Cancer
by: Yuncong Liu, et al.
Published: (2019-02-01)

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer
by: A. N. Niemeijer, et al.
Published: (2018-11-01)

Trypanosoma cruzi in dogs: electrocardiographic and echocardiographic evaluation, in Malinalco, State of Mexico
by: Gonz&aacute;lez-Vieyra SD, et al.
Published: (2011-12-01)

In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
by: Vishwanatha R. A. P. Reddy, et al.
Published: (2019-12-01)